Immunological persistence in 5 y olds previously vaccinated with hexavalent DTPa-HBV-IPV/Hib at 3, 5, and 11 months of age

The combined diphtheria-tetanus-acellular pertussis-hepatitis B-poliomyelitis/Haemophilus influenza vaccine (DTPa-HBV-IPV/Hib: Infanrix™ hexa, GlaxoSmithKline Vaccines) is used for primary vaccination of infants in a range of schedules world-wide. Antibody persistence after 4 DTPa-HBV-IPV/Hib doses...

Descripción completa

Detalles Bibliográficos
Autores principales: Silfverdal, Sven A, Assudani, Deepak, Kuriyakose, Sherine, Van Der Meeren, Olivier
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2014
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5443106/
https://www.ncbi.nlm.nih.gov/pubmed/25483640
http://dx.doi.org/10.4161/21645515.2014.970494

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5443106/
https://www.ncbi.nlm.nih.gov/pubmed/25483640
http://dx.doi.org/10.4161/21645515.2014.970494

Ejemplares similares